18 June and 30 June announces on very positive public exposures.
20 February Quarterly showed way forward with focus on meeting Novaquest hurdles, though noted throughout that sales not at expected levels. Aridol nicely up with clear impact in Korean market.
Are we missing anything positive that could happen?
Let's take a positive view for a second
-
- There are more pages in this discussion • 20 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add SNT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
3.3¢ |
Change
-0.001(2.94%) |
Mkt cap ! $39.40M | |||
| Open | High | Low | Value | Volume |
| 3.4¢ | 3.4¢ | 3.2¢ | $42.79K | 1.268M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 186833 | 3.3¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 3.4¢ | 252927 | 4 |
View Market Depth
| Last trade - 15.39pm 02/08/2024 (20 minute delay) ? |
| SNT (ASX) Chart |